1990 bolar copiagu n.y. generic drug concern
implic sell mislabel adulter
generic drug last year compani settl $ 40 million
major lawsuit smithklin beecham bolar effort
market generic version smithklin blood-pressur
medicin dyazid smithklin beecham inc. parent
smithklin beecham plc london-bas pharmaceut
concern
